Duration of type 2 diabetes strongly predicts all-cause and cardiovascular mortality in people referred for coronary angiography

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 551-557

  Silbernagel, Guenther ^a,b   Rosinger, Silke ^c   Grammer, Tanja B ^d   Kleber, Marcus E ^a   Winkelmann, Bernhard R ^e   Boehm, Bernhard O ^c   März, Winfried ^d,f,g  

^a LURIC Study Nonprofit LLC   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Cardiology Group Frankfurt Sachsenhausen   (Germany)

^f SYNLAB ACADEMY   (Germany)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

All cause mortality; Cardiovascular mortality; Duration of type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HAZARD RATIO; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; SELF REPORT; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; THORAX PAIN; UNSTABLE ANGINA PECTORIS; WAIST CIRCUMFERENCE;

ADULT; AGED; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84858708438     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.011     Document Type: Article

References (30)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
3. Schramm T.K., Gislason G.H., Køber L., et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008, 117:1945-1954.
4. Sarwar N., Gao P., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222. Emerging Risk Factors Collaboration.
5. Lenzen M., Ryden L., Ohrvik J., et al. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 2006, 27:2969-2974.
6. Barr E.L., Zimmet P.Z., Welborn T.A., et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007, 116:151-157.
7. Sourij H., Saely C.H., Schmid F., et al. Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients. Eur Heart J 2010, 31:1583-1590.
8. Kleinman J.C., Donahue R.P., Harris M.I., et al. Mortality among diabetics in a national sample. Am J Epidemiol 1988, 128:389-401.
9. Nelson R.G., Sievers M.L., Knowler W.C., et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 1990, 81:987-995.
10. Morrish N.J., Stevens L.K., Head J., et al. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics). II. Associated risk factors. Diabetologia 1990, 33:542-548.
11. Brun E., Nelson R.G., Bennett P.H., et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000, 23:1119-1123.
12. Cho E., Rimm E.B., Stampfer M.J., Willett W.C., Hu F.B. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002, 40:954-960.
13. Pavkov M.E., Bennett P.H., Knowler W.C., et al. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 2006, 296:421-426.
14. Wannamethee S.G., Shaper A.G., Whincup P.H., Lennon L., Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 2011, 171:404-410.
15. Winkelmann B.R., Marz W., Boehm B.O., et al. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2000, 2(1 Suppl. 1):S1-S73.
16. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
17. Friesinger G.C., Page E.E., Ross R.S. Prognostic significance of coronary arteriography. Trans Assoc Am Physicians 1970, 83:78-92.
18. de Groot V., Beckerman H., Lankhorst G.J., Bouter L.M. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003, 56:221-229.
19. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(Suppl. 1):S1-S266.
20. Saely C.H., Drexel H., Sourij H., et al. Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. Atherosclerosis 2008, 8:8.
21. Rizza S., Cardellini M., Martelli E., et al. Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation. Atherosclerosis 2010, 212:316-320.
22. Yun C.H., Schlett C.L., Rogers I.S., et al. Association between diabetes and different components of coronary atherosclerotic plaque burden as measured by coronary multidetector computed tomography. Atherosclerosis 2009, 205:481-485.
23. Taubert G., Winkelmann B., Schleiffer T., et al. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 2003, 145:285-291.
24. Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999, 281:2005-2012.
25. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
26. Rittig K., Hieronimus A., Thamer C., et al. Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals. Atherosclerosis 2010, 212:575-579.
27. Ryden L., Standl E., Bartnik M., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136.
28. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
29. Holman R.R., Paul S.K., Bethel M.A., Neil H.A., Matthews D.R. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008, 359:1565-1576.
30. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.